Live · 16 Sep 2026 SPX 7,585.73 -0.45% NDX 28,937.84 -0.65% VIX 17.20 +0.58% GOLD 4,364.00 +0.72% CL 104.69 -1.08% BTC 75,818.66 +0.00%
NAS100 28,938 −0.65% S&P 7,586 −0.45% GOLD $4,364 +0.72% BTC $75,819 VIX 17.20 +0.58% live tape · as of 11:00 UTC
The Screen · Basic Materials · Building Materials

CRH plc logoCRH plc

CRH · a US exchange · USD · Market cap $60.3B · 83,032 employees

CRH plc, together with its subsidiaries, provides building materials solutions in Ireland, the United States, the United Kingdom, rest of Europe, and internationally.

FAIL · Does not pass the screen
90.61 USD

At the last full screen
2026-09-08

Screened 2026-09-08 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its markdown label.

CRH plc holds its Markdown at $90.61. Consolidating, no directional conviction, held for 304 days.

As held on the ledger · 2026-09-08
PhaseMarkdown · caution
Quantitative stateConsolidating, no directional conviction, held for 304 days
Price at the screen$90.61
Valuation16.01 trailing · 13.72 forward price to earnings
Values screenFAIL · score 10.0
Beta1.20
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 33.78% Below 33% Interest-bearing debt is 33.8% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 14.39% Below 49% Money owed to the company is 14.4% of assets, under the 49% limit. Pass
Revenue purity 0.39% Below 5% Only 0.4% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

What the Numbers Say It Is Worth

The Fair Value Range

Our framework reads AVOID: it trades at roughly a 8% discount to our $97.83 fair value, narrow competitive moat, 5.60% revenue growth.

94.50Conservative97.83Base case112.50Growth case 90.61Price

Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 8.0% margin of safety to the base estimate.

The Street's Range
105.00Street low 139.85Street average 165.00Street high 90.61Price

Third-party analyst targets: 23 covering, consensus Strong Buy. The average target sits +54% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections
$175$106$37TODAY5y agoPROJECTIONStreet high$165.00 +64%Street avg$139.85 +39%Our fair value$97.83 -3%Conservative$94.50 -6%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Construction booms hide the cycle trap

Roads, offices and homes all need aggregates and cement, yet the building cycle rarely stays kind for long. CRH trades above our fair value with a negative margin of safety and a forward multiple that flatters peak earnings in a notoriously cyclical sector. We pass.

Revenue growth sits at nine percent and return on equity reaches sixteen percent, yet the narrow moat and ten percent profit margin leave little room for error once volumes turn. The ethical screen also flags excessive debt, ruling the name out regardless of analyst enthusiasm.

High debt and exposure to construction swings create real downside when rates stay elevated or spending slows. The apparent value is a warning, not an opportunity. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E13.7xexpensive even after accounting for its growth
Trailing P/E16.0xreasonably valued
EPS, trailing5.66
EPS, forward6.60
Revenue growth+5.6%slow but positive growth
Profit margin9.9%thin but positive margins
Return on equity15.8%a solid return on shareholder capital
FCF yield3.35%
Dividend yield137.00%
Debt to equity0.78moderate, manageable leverage
Current ratio1.58healthy short-term liquidity
Beta1.20moves a little more than the market
Short interest, float0.02%
52-week range90.21 - 131.55
MoatNARROW
Market cap$60.3B
Employees83,032

The risks · The things to watch: its business and earnings are exposed to Ireland and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CRH trades on a US exchange (the company is based in Ireland). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-08-29 Distribution $93.09 -6.8% Entry 11

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143.

2026-07-30 Distribution $99.87 +0.0% Entry 10

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-28 Distribution $99.87 +0.0% Entry 9

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-27 Distribution $99.87 +0.0% Entry 8

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-26 Distribution $99.87 +0.0% Entry 7

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-25 Distribution $99.87 -3.0% Entry 6

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-24 Distribution $102.92 +0.0% Entry 5

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-23 Distribution $102.92 -2.0% Entry 4

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-18 Distribution $105.06 +0.0% Entry 3

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 9%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it strong buy, with a mean price target of $143.

2026-07-03 Distribution $105.06 +0.0% Entry 2

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on CRH

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in CRH's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · CRH
DateInsiderTitleTypeSharesValue
2026-05-15 O'RIORDAIN PADRAIG Officer 1,492 $155,832
2026-05-13 FEARON RICHARD H Director 2,004 ·
2026-05-13 BOUCHER RICHARD AIDAN HUGH Director 3,339 ·
2026-05-13 MCKAY LAMAR Director 2,004 ·
2026-05-13 KHAN BADAR Director 2,004 ·
2026-05-13 MINTERN DENIS JAMES Chief Executive Officer 15,194 ·
2026-05-13 TALBOT SIOBHAN Director 2,004 ·
2026-05-13 DOWLING CAROLINE Director 2,004 ·
2026-05-13 PLATT GILLIAN L. Director 2,004 ·
2026-05-13 RHINEHART MARY K Director 2,004 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming CRH
DatePoliticianPartyTypeAmount
7 Jul2026 Ro Khanna Democrat sell 1K–15K
7 Jul2026 Ro Khanna Democrat sell 1K–15K
7 Jul2026 Ro Khanna Democrat sell 1K–15K
3 Aug2026 Ro Khanna Democrat buy 1K–15K
3 Aug2026 Ro Khanna Democrat buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $112.16 -10.4% $0.39 $900 -10.0%
2 months $117.46 -14.4% $0.39 $859 -14.1%
3 months $99.37 +1.2% $0.39 $1,015 +1.5%
6 months $126.09 -20.3% $0.78 $803 -19.7%
1 year $92.24 +9.0% $0.78 $1,098 +9.8%
2 years $77.66 +29.4% $2.22 $1,323 +32.3%
3 years $46.24 +117.4% $4.25 $2,266 +126.6%
5 years $46.10 +118.0% $7.74 $2,348 +134.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CRH does next, these words stay.

CRH plc · CRH · Markdown · $90.61
Recorded 2026-09-08 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.